Join to access to all OVN content. Join for Free

Results for 'COVID-19'

Oncology approvals in 2020: a year of firsts in the midst of a pandemic
OVN Avatar Laleh Amiri-Kordestani & Richard Pazdur
Oncology approvals in 2020: a year of firsts in the midst of a pandemic

oncology approvals, pandemic, FDA, biosimilar, oncology, COVID-19

Despite the global COVID-19 pandemic, 2020 was an active year for the OCE. In 2021, the OCE is engaging in Project 2025, an effort to envision the next 5 years in oncology drug development and leverage our resources and talents to improve collaboration with stakeholders to move the field forward as …

Jan 29th • 4 mins read

Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic
OVN Avatar Charles Oo, Barbara Ameer
Revamping the ever-changing landscape of drug development processes in the midst of COVID-19 pandemic

Oncology drug class, Cancer indication, Molecularly targeted, Drug Development

Oncology is the front-line of drug development. The current pharmaceutical pipeline is disproportional focused on oncology, where about 1/3 of all phases of development is in this therapeutic area. The emphasis brings about substantial breakthroughs and has made positive impact on the quality of lif…

Apr 29th • 2 mins read

Safeguarding cancer research funding by European charities amidst the COVID-19 pandemic
OVN Avatar Ioannis Tsagakis and Maria Papatriantafyllou
Safeguarding cancer research funding by European charities amidst the COVID-19 pandemic

cancer charities, cancer research, COVID‐19, funding, pandemic, policy, AECC, AIRC

The COVID-19 outbreak has had a significant impact on cancer research and cancer care. European cancer charities are required to reassess their strategies. There is a need to safeguard income and provide support to cancer researchers. It is crucial to sustain cancer research funding during thes…

Nov 22nd • 3 mins read

MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion
Partner Avatar Tom Caravela
MSL Hiring and Recruitment: 5 Ways to Support Diversity and Inclusion

Medical Science Liaison hiring, diversity and inclusion recruitment, diverse interview panel, employee referral program, diversity sourcing strategies

While the COVID-19 pandemic wreaked havoc on many industries, Medical Science Liaison hiring was steady throughout 2020 and continues to remain strong in 2021. The one change in hiring that has become evident is the increase in recruitment practices that support diversity and inclusion. While we may…

May 19th • 2 mins read

7 High-Cost Interview Mistakes that are Easy to Avoid
Partner Avatar Tom Caravela
7 High-Cost Interview Mistakes that are Easy to Avoid

digital marketing, content strategy, search engine optimization, keyword research, online visibility

Is your job search taking much longer than expected? Have you gone on interviews and feel it went well, but you still didn’t get the job? Interviewing in a competitive job market can be more challenging than one might think. COVID-19 has not made the interview process any easier – instea…

Jul 28th • 1 min read

MSL Evolution: New Trends and Titles That May Emerge
Partner Avatar Tom Caravela
MSL Evolution: New Trends and Titles That May Emerge

digital marketing strategies, SEO best practices, content marketing tips, social media optimization, keyword research tools

The COVID-19 pandemic has clearly had a profound impact on Field Medical Affairs. Has the Medical Science Liaison role changed forever? What new titles, trends and opportunities might emerge as a result of the new age for Field Medical and the evolution of the Medical Science Liaison? Is virtual en…

Apr 5th • 1 min read

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Virtual, Clinical trials, policy, analytics, telemedicine

The COVID-19 pandemic has significantly impacted clinical research, particularly in oncology, by accelerating the adoption of virtual clinical trials. These trials can address challenges such as high costs and participant burdens associated with traditional trials. Virtual Clinical Trials: Utiliz…

Apr 8th • 4 mins read

Related Topics

Loading...